Moradpour Z, Barghi L (2019) Novel approaches for efficient delivery of tyrosine inhibitors. J Pharm Pharm Sci 22:37–48

Article  CAS  PubMed  Google Scholar 

Mao LF, Wang ZZ, Wu Q, Chen X, Yang JX, Wang X, Li YM (2022) Desing synthesis and antitumor activity of erlotinib derivatives. Front Pharmacol 13:849364

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raymond E, Faivre S, Armand JP (2000) Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 60:15–23

Article  CAS  PubMed  Google Scholar 

Jahangiri A, Fakharonnesa K, Barghi L (2022) Dissolution improvement of binary solid dispersions of erlotinib prepared by one-step electrospray method. Biol Methods Protoc 7(1):001

Article  CAS  Google Scholar 

Drug approval package, United States Food and Drug Administration (FDA) Silver Spring

World Health Organization model list of essential medicines: 21st list 2019. World Health Organization

Khodayari P, Jalilian N, Ebrahimzadeh H, Amini S (2021) Trace-level monitoring of anti-cancer drug residues in wastewater and biological samples by thin-film solid-phase micro-extraction using electrospun polyfam/Co-MOF-74 composite nanofibers prior to liquid chromatography analysis. J Chromatogr A 1655:462484

Article  CAS  PubMed  Google Scholar 

Jadav RA, Ambasana MA, Bapodra AH (2022) Development and validation of the Ultraviolet spectrophotometric method for the determination of erlotinib hydrochloride. J Appl Spectrosc 89:417–475

Article  Google Scholar 

Rathod RD, Rathod LD, Mundada AB, Patel HM (2021) Validated UV spectrophotometric methods for determination of anticancer drug erlotinib hydrochloride in bulk and tablet formulation. J Appl Spectrosc 88:882–886

Article  CAS  Google Scholar 

Annapurna Matharusri M, Venkatesh B, Chaitanya K (2014) Analytical techniques for the determination of erlotinib HCl in pharmaceutical dosage form by spectrophotometry. Chem Sci Trans 3(2):840–846

Google Scholar 

Rasoulzadeh F, Asagari D, Naseri A, Rashidi M (2010) Spectroscopic studies on the interaction between erlotinib hydrochloride and bovin serum albumin. DARU J Pharm Sci 18(3):179–184

CAS  Google Scholar 

Rani GU, Chandrasekhar B, Devana N (2011) Extractive colorimetric method development and validation for erlotinib in bulk and tablet dosage form. J Appl Pharm Sci 1(7):176–179

Google Scholar 

Chakravarthy VK, Gowri Sankar D (2011) Development and validation of RP-HPLC method for estimation of erlotinib in bulk and its pharmaceutical formulation. Rasayan J Chem 4(2):393–399

CAS  Google Scholar 

Chandrasekhar K, Udupi A, Chandregovda V, Chandrasekhar G (2012) Separation and determination of process-related impurities of erlotinib using reverse-phase HPLC with a photo-diode array detector. Anal Sci 28:305–308

Article  Google Scholar 

Latha ST, Thangadurai A, Jambulingam M, Sereya K, Kamalaknnan D, Anil M (2017) Development and validation of RP-HPLC method for the estimation of erlotinib in pharmaceutical formulation. Arab J Chem 10(1):S1138-1144

Article  CAS  Google Scholar 

Saravanan VS, Rao BM (2013) Analytical method development and validation for the determination of erlotinib hydrochloride bulk and in pharmaceutical dosage form. JDDT 3(1):50–54

Article  CAS  Google Scholar 

Bolandnazar S, Divsalar A, Valizadeh H, Khodaej A, Zakeri-milani P (2013) Development and application of an HPLC method for erlotinib protein binding studies. Adv Pharm Bull 3(2):289–293

PubMed  PubMed Central  Google Scholar 

Lepper ER, Swain SM, Tam AR, Figg WD, Sppareboom A (2003) Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor. J Chromatogr B 796(1):181–188

Article  CAS  Google Scholar 

Pujeri SS, Khader AM, Seetharamappa J (2009) Validated stability indicating chromatographic method for the assay of erlotinib active pharmaceutical ingredient. Anal Lett 42(12):1855–1867

Article  CAS  Google Scholar 

Rajesh V, Anupama B, Jagathi V, Varaprasad K (2011) High performance thin layer chromatography method for estimation of erlotinib hydrochloride as bulk drug. IJBMR 2(1):433–435

Google Scholar 

Rajesh V, Jagathi V, Sindhuri K, Devela Rao G (2011) Spectrofluorometric method for the estimation of erlotinib hydrochloride in pure and pharmaceutical formulations. E-J Chem 8(S1):S304-308

Article  CAS  Google Scholar 

International Conferense on Harmonisation (2005) Q2R1, harmonized tripartite guideline, validation of analytical procedures: text and methodology. IFPMA, Geneva

Google Scholar